Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[New and future treatments for neurological disorders--knowledge essential to daily clinics and future prospects. Topics: 8. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy].
A case of acute disseminated encephalomyelitis disguised as mania in a woman with known bipolar disorder.
Multiple sclerosis: Diurnal variations in serum markers of inflammation-an avoidable source of bias in MS studies?
Acute Disseminated Encephalomyelitis After Plasmodium Vivax Infection: Case Report and Review of Literature.
Acute symptomatic sinus bradycardia in a woman treated with pulse dose steroids for multiple sclerosis: a case report.
Stem Cell Ophthalmology Treatment Study (SCOTS) for retinal and optic nerve diseases: a case report of improvement in relapsing auto-immune optic neuropathy.
N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities.
Political notebook.
Evaluating the Role of Coping Style as a Moderator of Fatigue and Risk for Future Cognitive Impairment in Multiple Sclerosis.
Early detection and favourable outcome of natalizumab-related progressive multifocal leukoencephalopathy (PML) in two multiple sclerosis patients.
THC:CBD Observational Study Data: Evolution of Resistant MS Spasticity and Associated Symptoms.
The relatively benign course of patients initially presenting with unilateral optic neuritis.
Antenarratives to inform health care research: exploring workplace illness disclosure for people with multiple sclerosis (MS).
Sex-related differences in atrophy and lesion load in multiple sclerosis patients.
The role of speed versus working memory in predicting learning new information in multiple sclerosis.
The Multiple Sclerosis Intimacy and Sexuality Questionnaire -- re-validation and development of a 15-item version with a large US sample.
Ustekinumab in chronic immune-mediated diseases: a review of long term safety and patient improvement.
Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis.
Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis.
Eight-and-a-half syndrome as presenting sign of childhood multiple sclerosis.
An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders.
Elevated serum anti-phosphatidylcholine IgG antibodies in patients with influenza vaccination-associated optic neuritis.
Interaction between passive smoking and two HLA genes with regard to multiple sclerosis risk.
Identification of biomarkers in cerebrospinal fluid and serum of multiple sclerosis patients by immunoproteomics approach.
Perfusion and Diffusion Abnormalities of Multiple Sclerosis Lesions and Relevance of Classified Lesions to Disease Status.
Pages
« first
‹ previous
…
445
446
447
448
449
450
451
452
453
…
next ›
last »